expert roundtables

Effectiveness of Current Therapies in Providing Neuroprotection for Patients With Relapsing-Remitting Multiple Sclerosis and Primary Progressive Multiple Sclerosis
Neurology

Effectiveness of Current Therapies in Providing Neuroprotection for Patients With Relapsing-Remitting Multiple Sclerosis and Primary Progressive Multiple Sclerosis

expert roundtables
By David A. Hafler, MD; Dean Wingerchuk, MD, FRCP(C), MSc; Staley Brod, MD
Individualizing Treatment for Patients With Multiple Sclerosis
Neurology

Individualizing Treatment for Patients With Multiple Sclerosis

expert roundtables
By David A. Hafler, MD; Dean Wingerchuk, MD, FRCP(C), MSc; Staley Brod, MD
Overcoming the Immunosuppressive Tumor Microenvironment in Metastatic Pancreatic Cancer
Oncology

Overcoming the Immunosuppressive Tumor Microenvironment in Metastatic Pancreatic Cancer

expert roundtables
By Alok Khorana, MD; Michael Morse, MD, MHS, FACP; Thomas A. Abrams, MD
Minimal Residual Disease Negativity in Chronic Lymphocytic Leukemia
Oncology

Minimal Residual Disease Negativity in Chronic Lymphocytic Leukemia

expert roundtables
By Anthony R. Mato, MD, MSCE; Jan A. Burger, MD, PhD; Jennifer R. Brown, MD, PhD
Oncology

Initiating Novel Agents Versus Chemoimmunotherapy in the Front-line Setting

expert roundtables
By Anthony R. Mato, MD, MSCE; Jan A. Burger, MD, PhD; Jennifer R. Brown, MD, PhD
Load More